News
-
The laboratory groups at Catalent RTP are responsible for the support of pharmaceutical product development in a range of dosage forms both directly with customers and in collaboration with other Catalent facilities. This includes formulation… Read more . . .
-
The laboratory groups at Catalent RTP are responsible for the support of pharmaceutical product development in a range of dosage forms both directly with customers and in collaboration with other Catalent facilities. This includes formulation… Read more . . .
-
Numerous studies have described the difficulties patients experience in using metered dose inhalers (MDIs), including a recent article in the Journal of General Internal Medicine (JGIM) that found 86% of hospitalized patients enrolled in a… Read more . . .
-
Chuck Bramlage has been appointed President and Chief Executive Officer of Pearl Therapeutics, replacing interim President and CEO Howard Rosen. Pearl, a California pharmaceutical company developing inhaled treatments for COPD and asthma, was founded in… Read more . . .
-
On the second day of the Drug Delivery to the Lungs meeting in December 2010 (DDL 21), Xiang Kou, a grad student from the National University of Singapore who had been spending time as a… Read more . . .
-
The Impactor Sub-Team of the European Pharmaceutical Aerosol Group (EPAG), a consortium of pharmaceutical companies that develop pulmonary and intranasal drugs, has focused its attention on the potential benefits of the abbreviated impactor method (AIM),… Read more . . .
-
At the next IPAC-RS conference, March 29-31 in Rockville, MD, sponsored by the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), OINDP specialists will have uncommon opportunities to interact with regulators, representatives of patient… Read more . . .
-
On Friday, December 10, just as the snow was beginning to melt in Edinburgh, DDL 21 concluded with one last podium session. Delegates also had a chance to spend some additional time at the exhibition.… Read more . . .
-
The second day of DDL 21 offered a wide variety of presentations, a focus on young investigators and the presentation of several awards, in addition to a continuation of the exhibition. By Day 2, most… Read more . . .
-
DDL 21 kicked off on Wednesday, December 8 with an EPAG workshop on the abbreviated impactor measurement (AIM) technique attended by 85 inhalation scientists who elected to attend the workshop in addition to the main… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal